These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32197340)

  • 1. MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS).
    Kotyla PJ; Islam MA
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.
    Pérez-Sánchez C; Arias-de la Rosa I; Aguirre MÁ; Luque-Tévar M; Ruiz-Limón P; Barbarroja N; Jiménez-Gómez Y; Ábalos-Aguilera MC; Collantes-Estévez E; Segui P; Velasco F; Herranz MT; Lozano-Herrero J; Hernandez-Vidal MJ; Martínez C; González-Conejero R; Radin M; Sciascia S; Cecchi I; Cuadrado MJ; López-Pedrera C
    Haematologica; 2018 May; 103(5):908-918. PubMed ID: 29545345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.
    Zhao Y; Cui S; Wang Y; Xu R
    Clin Appl Thromb Hemost; 2022; 28():10760296221093595. PubMed ID: 35536600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the deranged immune system in the antiphospholipid syndrome.
    van den Hoogen LL; van Roon JA; Radstake TR; Fritsch-Stork RD; Derksen RH
    Autoimmun Rev; 2016 Jan; 15(1):50-60. PubMed ID: 26318678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression in antiphospholipid syndrome: a systematic review and microRNA target genes analysis.
    Muhammad Shazwan S; Muhammad Aliff M; Asral Wirda AA; Hayati AR; Maizatul Azma M; Nur Syahrina AR; Nazefah AH; Jameela S; Nur Fariha MM
    Malays J Pathol; 2016 Dec; 38(3):273-283. PubMed ID: 28028298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modifications of proteins in antiphospholipid antibody syndrome.
    Buttari B; Profumo E; Capozzi A; Saso L; Sorice M; Riganò R
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):511-525. PubMed ID: 31448653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features.
    Alessandri C; Agmon-Levin N; Conti F; Perricone C; Ortona E; Pendolino M; Capozzi A; Delunardo F; Mancini R; Truglia S; Spinelli FR; Ceccarelli F; Sorice M; Shoenfeld Y; Valesini G
    Immunol Res; 2017 Apr; 65(2):524-531. PubMed ID: 28215033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid Syndrome--Not a Noninflammatory Disease.
    de Groot PG; Urbanus RT
    Semin Thromb Hemost; 2015 Sep; 41(6):607-14. PubMed ID: 26276935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts.
    Lackner KJ; Müller-Calleja N
    Expert Rev Clin Immunol; 2019 Feb; 15(2):199-209. PubMed ID: 30412684
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
    Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
    Front Immunol; 2019; 10():460. PubMed ID: 30923525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.
    Pérez-Sánchez C; Aguirre MA; Ruiz-Limón P; Barbarroja N; Jiménez-Gómez Y; de la Rosa IA; Rodriguez-Ariza A; Collantes-Estévez E; Segui P; Velasco F; Cuadrado MJ; Teruel R; González-Conejero R; Martínez C; López-Pedrera Ch
    Sci Rep; 2016 Aug; 6():31375. PubMed ID: 27502756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in autoimmunity and autoimmune diseases.
    Pauley KM; Cha S; Chan EK
    J Autoimmun; 2009; 32(3-4):189-94. PubMed ID: 19303254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
    Pérez-Sánchez L; Patiño-Trives AM; Aguirre-Zamorano MÁ; Luque-Tévar M; Ábalos-Aguilera MC; Arias-de la Rosa I; Seguí P; Velasco-Gimena F; Barbarroja N; Escudero-Contreras A; Collantes-Estévez E; Pérez-Sánchez C; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):865-877. PubMed ID: 33356391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The systemic nature of the antiphospholipid syndrome.
    Marai I; Zandman-Goddard G; Shoenfeld Y
    Scand J Rheumatol; 2004; 33(6):365-72. PubMed ID: 15794193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.